Viewing Study NCT00557232


Ignite Creation Date: 2025-12-24 @ 9:26 PM
Ignite Modification Date: 2026-02-27 @ 10:33 AM
Study NCT ID: NCT00557232
Status: COMPLETED
Last Update Posted: 2011-11-29
First Post: 2007-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intraocular Bevacizumab (Avastin) for Rubeosis Iridis
Sponsor:
Organization: